Fabian Fuchs on scaling under pressure and why AI is his next build. Some leaders operate. Others build. Fabian Fuchs does both and does it under pressure.From ...
To evaluate the potential for applying GMP-ready robotic systems to commercial-scale cell therapy manufacturing.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results